These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 8873551

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M.
    Brain Res; 2006 Apr 14; 1083(1):61-9. PubMed ID: 16530171
    [Abstract] [Full Text] [Related]

  • 4. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ, Członkowski A, Lipkowski A, Herz A.
    J Pharmacol Exp Ther; 1989 Oct 14; 251(1):342-50. PubMed ID: 2571723
    [Abstract] [Full Text] [Related]

  • 5. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG, West DC, Headley PM.
    Br J Pharmacol; 1989 Oct 14; 98(2):533-43. PubMed ID: 2555012
    [Abstract] [Full Text] [Related]

  • 6. Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release.
    Kondo I, Marvizon JC, Song B, Salgado F, Codeluppi S, Hua XY, Yaksh TL.
    J Neurosci; 2005 Apr 06; 25(14):3651-60. PubMed ID: 15814796
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE, Thompson J, Sun HS, Leitermann RJ, Fujimoto JM, Tseng LF.
    J Pharmacol Exp Ther; 2004 Jul 06; 310(1):240-6. PubMed ID: 14999057
    [Abstract] [Full Text] [Related]

  • 9. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J, Kendig JJ.
    Pain; 1996 Aug 06; 66(2-3):343-9. PubMed ID: 8880858
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK, Meert TF.
    J Pharmacol Exp Ther; 2002 Sep 06; 302(3):1253-64. PubMed ID: 12183687
    [Abstract] [Full Text] [Related]

  • 12. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A, Robertson JD, Willingham T.
    Brain Res; 1993 Feb 19; 603(2):186-200. PubMed ID: 8096421
    [Abstract] [Full Text] [Related]

  • 13. Mu and delta, but not kappa, opioid agonists induce spastic paraparesis after a short period of spinal cord ischaemia in rats.
    Kakinohana M, Nakamura S, Fuchigami T, Davison KJ, Marsala M, Sugahara K.
    Br J Anaesth; 2006 Jan 19; 96(1):88-94. PubMed ID: 16317029
    [Abstract] [Full Text] [Related]

  • 14. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1984 Aug 19; 230(2):341-8. PubMed ID: 6086883
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T, Mori T, Tsuji M, Maeda J, Kishimoto Y, Misawa M, Nagase H.
    Eur J Pharmacol; 1997 Apr 11; 324(1):21-9. PubMed ID: 9137909
    [Abstract] [Full Text] [Related]

  • 16. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF, Bettaney J, Perkins MN, Ketchum SB, Dray A.
    Br J Pharmacol; 1990 Mar 11; 99(3):503-8. PubMed ID: 2158845
    [Abstract] [Full Text] [Related]

  • 17. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.
    Fuchs PN, Roza C, Sora I, Uhl G, Raja SN.
    Brain Res; 1999 Mar 13; 821(2):480-6. PubMed ID: 10064835
    [Abstract] [Full Text] [Related]

  • 18. Effects of ibogaine on the development of tolerance to antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
    Cao YJ, Bhargava HN.
    Brain Res; 1997 Mar 28; 752(1-2):250-4. PubMed ID: 9106464
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular effects of intrathecally injected mu, delta and kappa opioid receptor agonists in rabbits.
    Oğütman C, Kaputlu I, Sadan G.
    J Auton Pharmacol; 1995 Dec 28; 15(6):443-50. PubMed ID: 8920161
    [Abstract] [Full Text] [Related]

  • 20. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE, Sun HS, Darpolar M, Leitermann RJ, Kampine JP, Tseng LF.
    J Pharmacol Exp Ther; 2003 Dec 28; 307(3):1135-41. PubMed ID: 14557378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.